CLASS II Device recall · Reported 24 Oct 2018 · FDA Enforcement Report

Affixus Hip Fracture Nail Right recalled by Zimmer Biomet

Zimmer Biomet is recalling Affixus Hip Fracture Nail Right 130, distributed nationwide in the US. The recall was initiated on 8 Aug 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: 201440
Quantity recalled22

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0157-2019
FDA event ID
81038
Recalling firm
Zimmer Biomet, Warsaw, IN
Classification
Class II
Status
Terminated
Recall initiated
8 Aug 2018
FDA classified
17 Oct 2018
Reported
24 Oct 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

8 Aug 2018Recall initiated by company
17 Oct 2018Classified by FDA+70 days
24 Oct 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Affixus Hip Fracture Nail Right 130 9 mm x 320 mm, Item Number 814509320 Product Usage: Intended for the fixation of fractures

Where it was distributed

Worldwide Distribution - US Nationwide in the states of: AK, AL, AR, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WY. The products were distributed to the following foreign countries: Chile, Netherlands.

Nationwide AlaskaAlabamaArkansasArizonaCaliforniaColoradoFloridaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaineMichigan

Questions about this recall

Is Affixus Hip Fracture Nail Right 130 recalled?

Yes. Zimmer Biomet recalled Affixus Hip Fracture Nail Right 130 on 8 Aug 2018. The recall is Class II and its status is Terminated. Recall number Z-0157-2019.

Why was it recalled?

There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.

Which lots are affected?

Lot Numbers: 201440

Where was it sold?

Worldwide Distribution - US Nationwide in the states of: AK, AL, AR, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WY. The products were distributed to the following foreign countries: Chile, Netherlands.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zimmer Biomet

All 873

Other Hip & Knee Implants recalls

All 3,097